MindMed Provides Corporate Update and 2023 Outlook

/PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing...

Related Keywords

Canada ,Switzerland ,San Francisco ,California ,United States ,Canadian ,Rob Barrow ,Exchange Commission ,Company Annual Report On Form ,Development Program Updates ,Prnewswire Mind Medicine Mindmed Inc ,University Hospital Basel ,Company Or Mindmed ,Nasdaq ,Chief Executive ,Program Updates ,Anticipated Milestones ,Annual Report ,Quarterly Report ,Note Regarding Forward Looking Statements ,Financial Condition ,Mind Medicine Mindmed Inc ,